Immunotherapy is going to be the solution to put an end to cancer. We have discovered a new way to deliver messages to immune system. We are co-developing our products with two partners, Merck and Insight. It has the potential to transform the way we work with our immune system.
We believe that the key to leveraging the power of human immunity resides in the way we communicate with our immune system. Modern medicine has created access to technologically advanced targets—proteins, peptides, DNA/RNA vaccines—that can be used to encode directives to our immune system. But those commands are secondary, as our immune systems have already evolved over millions of years to precisely and powerfully recognize and respond to a wide variety of danger signals.
For more information on Immunovaccine Inc (IMV.TO) please fill out the form.